Balchem Co. (NASDAQ:BCPC) Stock Holdings Decreased by Teacher Retirement System of Texas

Teacher Retirement System of Texas cut its holdings in Balchem Co. (NASDAQ:BCPC) by 11.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,038 shares of the basic materials company’s stock after selling 680 shares during the period. Teacher Retirement System of Texas’ holdings in Balchem were worth $749,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Signaturefd LLC boosted its holdings in shares of Balchem by 123.0% in the 4th quarter. Signaturefd LLC now owns 165 shares of the basic materials company’s stock valued at $25,000 after buying an additional 91 shares during the period. Principal Securities Inc. acquired a new position in shares of Balchem in the 4th quarter valued at about $28,000. Operose Advisors LLC acquired a new position in shares of Balchem in the 3rd quarter valued at about $31,000. GAMMA Investing LLC acquired a new position in shares of Balchem in the 4th quarter valued at about $56,000. Finally, Allworth Financial LP boosted its holdings in shares of Balchem by 17.8% in the 4th quarter. Allworth Financial LP now owns 953 shares of the basic materials company’s stock valued at $142,000 after buying an additional 144 shares during the period. 87.91% of the stock is owned by institutional investors and hedge funds.

Balchem Trading Down 0.9 %

Balchem stock opened at $153.75 on Friday. The company has a quick ratio of 1.72, a current ratio of 2.61 and a debt-to-equity ratio of 0.30. The firm has a 50-day moving average price of $150.82 and a two-hundred day moving average price of $143.92. The firm has a market capitalization of $4.98 billion, a price-to-earnings ratio of 43.43, a PEG ratio of 3.67 and a beta of 0.72. Balchem Co. has a 52-week low of $110.74 and a 52-week high of $159.52.

Insider Buying and Selling at Balchem

In other Balchem news, CAO William A. Backus sold 7,000 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $155.19, for a total transaction of $1,086,330.00. Following the sale, the chief accounting officer now directly owns 5,914 shares in the company, valued at approximately $917,793.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, SVP Michael Robert Sestrick sold 1,929 shares of the business’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $154.45, for a total value of $297,934.05. Following the sale, the senior vice president now directly owns 4,878 shares in the company, valued at approximately $753,407.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO William A. Backus sold 7,000 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $155.19, for a total transaction of $1,086,330.00. Following the completion of the sale, the chief accounting officer now owns 5,914 shares in the company, valued at $917,793.66. The disclosure for this sale can be found here. Insiders sold 13,929 shares of company stock valued at $2,149,164 in the last ninety days. Company insiders own 1.25% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on BCPC shares. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a report on Friday, May 10th. HC Wainwright boosted their target price on shares of Balchem from $167.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, May 6th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.